Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 known ✓ | Q99720 | 1/20 | 0.43 |
| ▸ | EGFR known ✓ | P00533 | 1/20 | 0.39 |
| ▸ | HDAC3 known ✓ | O15379 | 1/20 | 0.39 |
| ▸ | HDAC1 known ✓ | Q13547 | 1/20 | 0.39 |
| ▸ | HDAC2 known ✓ | Q92769 | 1/20 | 0.39 |
| ▸ | KCNH3 known ✓ | Q9ULD8 | 1/20 | 0.38 |
| ▸ | NAAA | Q02083 | 3/20 | 0.44 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | CNR1 | P21554 | 1/20 | 0.38 |
| ▸ | CNR2 | P34972 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2122029 | 1.00 | NAAA (0.44) | NAAASIGMAR1EPHX1ALDH1A1HTT | |
| Hydrochloric Acid SCHEMBL959789 | 1.00 | NAAA (0.44) | NAAASIGMAR1EPHX1ALDH1A1HTT | |
| Hydrochloric Acid SCHEMBL28065304 | 1.00 | NAAA (0.44) | NAAASIGMAR1EPHX1ALDH1A1HTT | |
| Hydrochloric Acid SCHEMBL29054346 | 1.00 | NAAA (0.44) | NAAASIGMAR1EPHX1ALDH1A1HTT | |
| Hydrochloric Acid SCHEMBL29054370 | 1.00 | NAAA (0.44) | NAAASIGMAR1EPHX1ALDH1A1HTT | |
| Hydrochloric Acid SCHEMBL755158 | 1.00 | NAAA (0.44) | NAAASIGMAR1EPHX1ALDH1A1HTT | |
| Hydrochloric Acid SCHEMBL97019 | 1.00 | NAAA (0.44) | NAAASIGMAR1EPHX1ALDH1A1HTT | |
| Hydrochloric Acid SCHEMBL6803724 | 1.00 | NAAA (0.44) | NAAASIGMAR1EPHX1ALDH1A1HTT | |
| Hydrochloric Acid SCHEMBL93430 | 1.00 | NAAA (0.44) | NAAASIGMAR1EPHX1ALDH1A1HTT | |
| Hydrochloric Acid SCHEMBL5797433 | 0.98 | NAAA (0.42) | NAAASIGMAR1EPHX1ALDH1A1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 257 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119214430-A | Preparation of antibacterial anti-mite healthy coated yarn mattress | 和也健康科技有限公司 | 2024-12-31 | — | — | CN | claimed |
| CN-118495546-A | Mesoporous silica material with oversized opening and preparation method thereof | 山东固立特新材料科技有限公司 | 2024-08-16 | — | — | CN | claimed |
| CN-118085117-A | Modified welan gum with salt thickening effect and preparation method and application thereof | 常州大学 | 2024-05-28 | — | — | CN | claimed |
| CN-116496524-B | Furniture skin-feel decorative film and preparation method thereof | 河源市万利科技有限公司 | 2024-04-02 | — | — | CN | claimed |
| CN-117752541-A | Durable antibacterial wet tissue for objects and preparation method thereof | 福建恒安集团有限公司 | 2024-03-26 | — | — | CN | claimed |
| CN-117230490-A | Electrolyte for electrolyzing and recycling copper from acidic etching waste liquid and application method of electrolyte | 广东德同环保科技有限公司 | 2023-12-15 | — | — | CN | claimed |
| CN-117089334-A | Corrosion inhibitor for oil extraction and preparation method thereof | 德蓝(海南)未来之水有限公司 | 2023-11-21 | — | — | CN | claimed |
| CN-116806139-A | Dual phase composition for cleansing and/or removing makeup from keratin materials | 莱雅公司 | 2023-09-26 | — | — | CN | claimed |
| CN-116496524-A | Furniture skin-feel decorative film and preparation method thereof | 河源市万利科技有限公司 | 2023-07-28 | — | — | CN | claimed |
| CN-116349679-A | Composite disinfection and sterilization method | 孙国明 | 2023-06-30 | — | — | CN | claimed |
| EP-1819229-A2 | COMPOSITIONS HAVING A HIGH ANTIVIRAL AND ANTIBACTERIAL EFFICACY | The Dial Corporation (US) | 2007-08-22 | — | — | EP | claimed |
| EP-1819222-A2 | COMPOSITIONS HAVING A HIGH ANTIVIRAL AND ANTIBACTERIAL EFFICACY | The Dial Corporation (US) | 2007-08-22 | — | — | EP | claimed |
| WO-2007019115-A1 | CONDUCTIVE ADHESIVES AND BIOMEDICAL ARTICLES INCLUDING SAME | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2007-02-15 | — | — | WO | claimed |
| US-20070032719-A1 | Conductive adhesives and biomedical articles including same | 3M INNOVATIVE PROPERTIES COMPANY | 2007-02-08 | — | — | US | claimed |
| WO-2006105669-A1 | ANTIMICROBIAL SOLUTION COMPRISING A METALLIC SALT AND A SURFACTANT | CTT GROUP INC. (CA) | 2006-10-12 | — | — | WO | claimed |
| WO-2006062845-A2 | COMPOSITIONS HAVING A HIGH ANTIVIRAL AND ANTIBACTERIAL EFFICACY | THE DIAL CORPORATION (US) | 2006-06-15 | — | — | WO | claimed |
| WO-2006062846-A2 | COMPOSITIONS HAVING A HIGH ANTIVIRAL AND ANTIBACTERIAL EFFICACY | THE DIAL CORPORATION (US) | 2006-06-15 | — | — | WO | claimed |
| US-6616922-B2 | For use in cleansing formulations to cleasne the skin and to destroy bacteria and other microorganisms present on the skin, especially the hands, arms, and face of the user | THE DIAL CORPORATION | 2003-09-09 | — | — | US | claimed |
| US-20030022941-A1 | For use in cleansing formulations to cleasne the skin and to destroy bacteria and other microorganisms present on the skin, especially the hands, arms, and face of the user | Henkel IP & Holding GmbH (DE) | 2003-01-30 | — | — | US | claimed |
| WO-2002076207-A1 | ANTIBACTERIAL COMPOSITIONS | THE DIAL CORPORATION (US) | 2002-10-03 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030022941-A1 | For use in cleansing formulations to cleasne the skin and to destroy bacteria and other microorganisms present on the skin, especially the hands, arms, and face of the user | CUTA, CHIT1, CLSPN | SIGMAR1 420/4885EGFR 298/4885HDAC3 4514/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.